ACR Concerned with MedPAC’s Cutting Part B Reimbursement ACR took issue with the orgs reco to Congress to keep a 6% add-on payment for the lowest-cost drugs, reduce the add-on payment for mid-to-high-level drugs, and add a payment cap for the $$$ drugs. https://t.co/IwZO88QThb https://t.co/GHjDwbHCCo